Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Expert Reviews in Molecular Medicine|February 28, 2004
Molecular pathogenesis of chronic myeloid leukaemiaDuncan L Smith, John Burthem, Anthony D WhettonRapid Communications in Mass Spectrometry : RCM|August 15, 2013
Chemically facilitating the generation of diagnostic ions from SUMO(2/3) remnant isopeptidesNavin Chicooree, John R Griffiths, Yvonne Connolly, et al.Scientific Reports|October 17, 2023
Functional classification of DDOST variants of uncertain clinical significance in congenital disorders of glycosylationSjors M Kas, Piyushkumar A Mundra, Duncan L Smith, et al.The Journal of Cell Biology|November 20, 2013
Phosphorylation of the TOR ATP binding domain by AGC kinase constitutes a novel mode of TOR inhibitionLenka Hálová, Wei Du, Sara Kirkham, et al.Nature Cell Biology|June 12, 2012
The S. pombe cytokinesis NDR kinase Sid2 activates Fin1 NIMA kinase to control mitotic commitment through Pom1/Wee1Agnes Grallert, Yvonne Connolly, Duncan L Smith, et al.Aging|November 6, 2015
Proteomic identification of prognostic tumour biomarkers, using chemotherapy-induced cancer-associated fibroblastsMaria Peiris-Pagès, Duncan L Smith, Balázs Győrffy, et al.Molecular & Cellular Proteomics : MCP|December 19, 2002
Changes in the proteome associated with the action of Bcr-Abl tyrosine kinase are not related to transcriptional regulationDuncan L Smith, Caroline A Evans, Andrew Pierce, et al.Plos One|February 4, 2010
An integrated mass-spectrometry pipeline identifies novel protein coding-regions in the human genomeDanny A Bitton, Duncan L Smith, Yvonne Connolly, et al.Oncotarget|November 22, 2014
Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibitionRebecca Lamb, Hannah Harrison, James Hulit, et al.Plos One|November 13, 2015
Absolute Quantification of Endogenous Ras Isoform AbundanceCraig J Mageean, John R Griffiths, Duncan L Smith, et al.Pageof 4